Prostate brachytherapy:Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry-Reference-Cited by-同舟云学术

Prostate brachytherapy:Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry

Published:1995 Issue:4 Volume:3 Page:185-195
ISSN:1065-7541
Container-title:Radiation Oncology Investigations
language:en
Short-container-title:Radiat. Oncol. Investig.

Author:

Stone Nelson N.,Stock Richard G.,Keith DeWyngaert J.,Tabert Andrea

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Radiological and Ultrasound Technology,Radiation

Reference31 articles.

1. Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

2. I–125 interstitial implantation for prostate cancer. What have we learned 10 years later?

3. External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma

4. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer

5. The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 1251 implantation

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective analysis after low-dose-rate prostate brachytherapy with permanent 125I seed implant: clinical and dosimetric results in 70 patients;Tumori Journal;2011-05

2. Needle position during 125I seed implantation: accurately recognized by sagittal transrectal ultrasonography;Radiation Medicine;2008-10

3. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era?;International Journal of Radiation Oncology*Biology*Physics;2008-10

4. Comparison of intraoperative ultrasound with postimplant computed tomography–dosimetric values at Day 1 and Day 30 after prostate brachytherapy;Brachytherapy;2007-10

5. Long-Term Urinary, Sexual, and Rectal Morbidity in Patients Treated with Iodine-125 Prostate Brachytherapy Followed Up for a Minimum of 5 Years;Urology;2007-02